A West Virginia jury has told C.R. Bard, the maker of the Bard Avaulta line of vaginal mesh products, that the company is liable for injuries sustained by a woman who had an Avaulta mesh device implant and ordered Bard to pay her $2 million in damages.
In an earlier blog, the vaginal mesh injury attorneys at Farah & Farah in Jacksonville reported that the original federal bellwether trial had been halted because a mistrial had been declared by the presiding judge.
This trial was a continuation of that case.
Read the rest »
Recently, PBS ran a documentary in the series “Need To Know” calling into question the effectiveness of a U.S. Food and Drug Administration’s (FDA) medical device evaluation process. The documentary highlighted the case of a South Dakota nurse who had an implanted Johnson & Johnson’s Gynecare Prolift mesh device to treat her prolapsed pelvic organ.
The woman was also recently awarded more than $11 million in compensatory and punitive damages after a New Jersey jury found that Ethicon, the J&J unit responsible for the manufacture and distribution of the Prolift, had failed to adequately warn about health risks. Read the rest »
The vaginal mesh injury lawyers in Jacksonville at Farah & Farah recently reported that a jury in Atlantic City, New Jersey awarded $3.35 million in compensatory damages to a woman who claimed that Johnson’s and Johnson’s Gynecare Prolift mesh product was defective, that J&J knew it, and that the medical device manufacturer had failed to adequately warn about its risks.
The same jury has ordered Johnson and Johnson to pay the plaintiff an additional $7.76 million in punitive damages — making the total award some $11.1 million. Read the rest »
The first trial over whether Johnson & Johnson failed to adequately warn about the potential dangers of the Gynecare Prolift vaginal mesh implant is over — and the jury has awarded the plaintiff $3.5 million.
The trial, which took place in State Superior Court in Atlantic City, New Jersey, was the first in the some 1,800 cases pending against J&J and its Ethicon unit concerning the Gynecare Prolift’s adverse effects. This Bellwether transvaginal mesh trial verdict is seen by many experts as possibly setting a precedent for those lawsuits and thousands of similar suits brought against companies that have manufactured similar vaginal mesh products. Read the rest »
Transvaginal mesh injury attorney Eddie Farah has been following developments in the first of 1,800 lawsuits slated to go to trial concerning injuries caused by Johnson & Johnson’s defective Gynecare Prolift vaginal mesh implant.
Jurors heard final arguments in the trial, which was held in state court in New Jersey beginning in January. During summation, the plaintiff’s attorney accused Johnson & Johnson’s Ethicon unit of hiding the Prolift’s risks before it was implanted in his client. He argued that J&J knew of the risks even before the device was introduced in March of 2005. Read the rest »
The first trial over Johnson & Johnson’s Gynecare Prolift vaginal mesh device has begun in New Jersey. The lawsuit was brought by a South Dakota woman who claims that she is in constant pain due to the failed transvaginal mesh and that she had to undergo 18 subsequent surgeries to repair damage caused by the Gynecare Prolift.
This is the first of some 1,800 lawsuits filed in New Jersey state court to go to trial. The 47-year-old plaintiff alleges that J&J’s Ethicon unit inadequately tested the device and failed to warn about the risks of the vaginal mesh product. Read the rest »
The Jacksonville transvaginal mesh injury attorneys at Farah & Farah have been alerted to a new lawsuit filed by a Florida woman against American Medical Systems (AMS). The woman alleges she suffered serious complications from the company’s AMS Monarc Subfacial Hammock mesh device.
The complaint contends the woman had surgery to have the Monarc Subfascial Hammock implanted in 2008 because she had been suffering from stress urinary incontinence and pelvic organ prolapse. The lawsuit goes on to allege that she suffered permanent injuries from the device that led to “significant mental and physical pain and suffering.” Read the rest »
In recent years, thousands of patients who have received transvaginal mesh implants have suffered serious side effects from transvaginal mesh failures. And now, a recent study is showing that even when revision surgeries to correct complications from failed mesh implants are performed, women are in worse shape than they were before their original mesh surgery.
The study was conducted by a urologist at the Weill Cornell Medical College in New York, who reviewed 47 cases from 1998 to 2011 in which he performed corrective surgery after at least one prior attempt to correct mesh complications. What he found was that nearly 72 percent of the operations were considered “successful,” but that “success” was relative for many patients. Read the rest »
A jury in California has found C.R. Bard, Inc. liable for $3.6 million in damages for injuries caused by its Avaulta Plus vaginal mesh implant. This was the first case — among the hundreds of lawsuits pending against Bard and other vaginal mesh manufacturers — to go to trial over the controversial medical devices.
The attorneys for the plaintiff claimed that after Bard’s Avaulta Plus had been implanted in their client in 2008, it eroded, subsequently leaving the woman incontinent and in chronic pain. The lawyers claimed the transvaginal mesh manufacturer had been negligent in its handling of the devices. Read the rest »
Johnson & Johnson’s Ethicon unit has told a federal judge that it intends to stop selling four vaginal mesh implants. This announcement comes in the wake of lawsuits filed by over 600 women who claim the products were defective and caused internal injuries.
In a letter filed with the U.S District Judge who is overseeing mesh implant litigation in West Virginia, Johnson & Johnson said that it is also seeking U.S. Food and Drug Administration (FDA) approval to stop “commercializing” the devices. A spokesman for Ethicon said in an email to Bloomberg News that it intends to stop sales worldwide. Read the rest »